Maternal near miss and quality of maternal health care in Baghdad, Iraq by Maysoon Jabir et al.
Jabir et al. BMC Pregnancy and Childbirth 2013, 13:11
http://www.biomedcentral.com/1471-2393/13/11RESEARCH ARTICLE Open AccessMaternal near miss and quality of maternal health
care in Baghdad, Iraq
Maysoon Jabir1, Imad Abdul-Salam2, Dhikra M Suheil3, Wafa Al-Hilli4, Sana Abul-Hassan5, Amal Al-Zuheiri6,
Rasha Al-Ba'aj7, Abeer Dekan1, Özge Tunçalp8* and Joao Paulo Souza9Abstract
Background: The maternal near-miss concept has been developed as an instrument for assisting health systems to
evaluate and improve their quality of care. Our study aimed at studying the characteristics and quality of care
provided to women with severe complications in Baghdad through the use of the World Health Organization
(WHO) near-miss approach for maternal health.
Methods: This is a facility-based, cross-sectional study conducted in 6 public hospitals in Baghdad between March
1, 2010 and the June 30, 2010. WHO near-miss approach was utilized to analyze the data in terms of indicators of
maternal near miss and access to and quality of maternal care.
Results: The maternal near-miss rate was low at 5.06 per 1,000 live births, while the overall maternal near miss:
mortality ratio was 9:1. One third of the near-miss cases were referred from other facilities and the mortality index
was the same for referred women and for in-hospital women (11%). The intensive care unit (ICU) admission rate
was 37% for women with severe maternal outcomes (SMO), while the overall admission rate was 0.28%. Anemia
(55%) and previous cesarean section (45%) were the most common associated conditions with severe maternal
morbidity. The use of magnesium sulfate for treatment of eclampsia, oxytocin for prevention and treatment of
postpartum hemorrhage, prophylactic antibiotics during caesarean section, and corticosteroids for inducing fetal
lung maturation in preterm birth is suboptimum.
Conclusions: The WHO near-miss approach allowed systematic identification of the roadblocks to improve quality
of care and then monitoring the progress. Critical evidence-based practices, relevant to the management of
women experiencing life-threatening conditions, are underused. In addition, possible limitations in the referral
system result in a very high proportion of women presenting at the hospital already in a severe health condition (i.
e. with organ dysfunction). A shortage of ICU beds leading to women taken care of without admission to ICU may
also contribute to a high proportion of maternal deaths and organ dysfunction.
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In 2000, the leaders of all United Nations Member States
agreed that policies conducive to development and to
the elimination of extreme poverty would be put in place
in global scale. A set of goals has been established and
many countries have done a substantial progress towards
those goals, which became known as the Millennium
Development Goals (MDGs) [1]. In Iraq, progress* Correspondence: otuncalp@jhsph.edu
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reproduction in any medium, provided the ortowards achievement of MDGs has been challenged by
two major wars in the last two decades. On top of the
unbearably high human cost, these wars have produced
an important damage to the country’s infrastructure and
affected various components of the health systems.
Social determinants and the health system perform-
ance play a major role in the occurrence of maternal
deaths. One of the MDGs, reduction of maternal mortal-
ity is a robust indicator of development. In this context,
even with the two wars, since 1990 there is a trend to-
wards reduction of maternal mortality in Iraq. Thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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maternal mortality in Iraq was around 93 deaths per
100,000 live births, while in 2008, it was estimated to be
around 75 deaths per 100,000 live births [2]. Recent esti-
mates are compatible with this trend [3], which is most
likely due to the resilience of Iraqi people in keeping
basic infrastructure and services functional under ad-
verse conditions and, possibly, the substantial efforts for
reconstruction have produced some visible effect.
Confidential enquiries and similar clinical audits of ma-
ternal deaths have been used to evaluate and improve the
quality of maternal health care in many countries. How-
ever, as maternal deaths become less frequent or are found
to be relatively rare in individual health facilities, the as-
sessment of quality of care performed exclusively based on
maternal deaths becomes more challenging. The concept
of maternal near miss has been evolving during the past
two decades as number of women dying from complica-
tions of pregnancy and childbirth is progressively decreas-
ing in many countries, while the number of those with
life-threatening complications who are treated and dis-
charged home exceeds the number of those who die.
Therefore, studying those women who nearly died but sur-
vived, identified as the near-miss cases, would give a better
indication of care provided for those women who survived
the near-miss event [4].
Overall, there had been three major approaches to the
identification of near miss cases: 1) Clinical criteria related
to a specific disease entity (i.e., pre-eclampsia, postpartum
hemorrhage), 2) Management-based criteria (i.e., admis-
sion to ICU, need for a blood transfusion), or 3) Organ
system dysfunction based criteria [5,6]. Depending on
these different approaches, prevalence of near miss varies.
According to a recent systematic review, prevalence rates
of near miss varied between 0.6 and 14.98% for disease-
specific criteria, between 0.04 and 4.54% for management-
based criteria and between 0.14 and 0.92% for organ-
based dysfunction based on Mantel criteria [7]. Women in
resource-poor settings experience a higher prevalence in
all these categories. However, due to wide variation in
identification of cases as well as the variation within each
category, it has not been possible to pool the data and
make a summary estimate [4,7]. Currently, a maternal
near-miss case is defined as "a woman who nearly died but
survived a complication that occurred during pregnancy,
childbirth or within 42 days of termination of pregnancy”
[8]. In order to overcome these challenges, the maternal
near-miss concept has been developed as an instrument
for assisting health systems to evaluate and improve their
quality of care. In recent years, WHO has developed a tool
for evaluating the quality of maternal health care based on
the near-miss concept [9].
In an attempt to standardize the identification of ma-
ternal near-miss events, the WHO working group formaternal mortality and morbidity classifications devel-
oped a consensus on maternal near-miss identification
(Additional file 1: Table S1), which is based on two
components [8]:
1. Identification of potentially life-threatening
conditions, which may or may not be near-miss cases
(i.e. specific complications such as severe
preeclampsia and/or critical interventions such as
blood transfusion).
2. Identification of near-miss cases based on organ
system dysfunction and organ-dysfunction proxies
including clinical, laboratory and management
criteria.
Our study aims at assessing the prevalence and evalu-
ating the management of severe maternal morbidity
using the WHO near-miss approach in Baghdad, Iraq
[9]. This is the first multi-center study conducted in the
city of Baghdad to assess the near-miss cases in obstetric
practice in Iraq.
Methods
This is a facility-based, cross-sectional study conducted
in six public hospitals in Baghdad between March 1,
2010 and the June 30, 2010. It consists of a near-miss
criterion-based clinical audit implemented according the
WHO near-miss approach for maternal health [6]. Selec-
tion criteria for the facilities included were 1) to be a
public hospital and 2) to have more than one thousand
deliveries per year according to the information provided
by the health and biostatistics department in the Iraqi
Ministry of Health. We included all of the hospitals fit-
ting these criteria in Baghdad: a total of six. These public
hospitals were distributed all over Baghdad city to serve
a population of approximately seven millions. Three of
these hospitals were general hospitals with obstetric
units and the rest were major maternity hospitals. Four
out of six hospitals had intensive care units (ICUs),
although the remaining two hospitals had a "close
observation unit" to monitor and treat women with
post-operative and post-delivery complications, run by
specialized obstetricians. These hospitals receive refer-
rals from midwives, health centers, private hospitals as
well as unbooked patients (patients self-referring them-
selves to the hospitals). No fees are paid by patients for
the services provided.
A study coordinator among the hospital coordinators
was designated in each of these six facilities and the
overall study coordination was performed by the Centre
of Training and Human Development in the Iraqi Minis-
try of Health. These six selected study coordinators were
trained on a two-day course in January 2010 on identify-
ing severe life-threatening conditions, maternal near-
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collection.
The WHO consensus on maternal near-miss definition
was used to define the cases [8]. Definitions and abbre-
viations used in this paper are found in Table 1. Data
were collected on a daily basis by the coordinators using
hospital records or staff interviews and the forms were
filled while the women were still in the hospital. Cases
were defined according to potentially life-threatening
conditions including severe postpartum hemorrhage,
severe preeclampsia, eclampsia, sepsis and ruptured
uterus, whereas organ or system failure depending on
certain clinical criteria, laboratory markers and manage-
ment proxies were used to identify the near-miss cases
among potentially life-threatening conditions (Additional
file 1: Table S1). The maternal outcome, gestational age
and neonatal outcome were also collected during the
hospital stay or by the 7th day postpartum, whichever
came first.
Using the data collected, various indicators have been
calculated. In line with maternal mortality ratio, mater-
nal near-miss ratio was the number of near-miss cases
per 1000 live births. Moreover, maternal near-miss mor-
tality ratio, which is the ratio between maternal near-
miss cases and maternal deaths, was calculated. For this
indicator, higher ratios indicate better care, meaning
more women survived as a near miss rather than be-
coming maternal deaths. Also, mortality index was cal-
culated, where the number of maternal deaths was
divided by the number of women with life-threatening
conditions (maternal near miss and maternal deaths)
and was expressed as a percentage. Higher indices indi-
cate that more women with life-threatening conditions
die (low quality of care), whereas lower indices signify
better quality of care.
Access to hospital and intra-hospital care were assessed
by the proportion of near-miss cases and maternal deaths
presenting within 12 hours of hospital stay versus after
12 hours, the latter indicating the quality of care provided
within the hospital. Intensive care unit (ICU) use among
our study population was collected as well.
We also collected data on the coverage of selected
evidence-based interventions used for prevention and
treatment of the main causes of maternal deaths. This
was part of a criterion-based clinical audit approach
used to assess the quality of care and included interven-
tions related to the prevention and treatment of postpar-
tum hemorrhage, severe preeclampsia and eclampsia,
use of antibiotics for infection prophylaxis during caesar-
ean section (C-section) and treatment of sepsis. In
addition, we measured the use of corticosteroids for fetal
lung maturity.
Data were sent monthly to the country coordinator
and subsequently entered into an online data entrysystem. This online data management system was based
on the Google platform and data entered in the online
form were stored in an online spreadsheet, which incor-
porated a comprehensive set of consistency rules to pro-
vide concurrent data quality check. The inconsistencies
that were identified generated queries to the study coor-
dinators. The standard data tables based on the WHO
near-miss approach was automatically generated using
Microsoft Excel as the data were entered. The online
data entry system was password protected.
The study was approved by the ethics committee of
the local supervising committee of the Arab Board for
Health Specializations (ABHS). All data were obtained
from medical records and did not identify participants,
therefore each site was granted a waiver of individual
informed consent.
Results
During the four-month data collection period in the six
study facilities, overall there were 25,472 live births, 212
women with potentially life threatening conditions and
145 severe maternal outcomes (129 near-miss cases and
16 maternal deaths). Our results will be presented as
suggested in the WHO handbook on the near-miss ap-
proach for maternal health [9].
Cases were identified according to underlying causes of
morbidity and organ system dysfunction in Tables 2 and 3,
respectively. Most common organ dysfunctions reported
among near-miss cases were cardiovascular dysfunction
followed by uterine dysfunction leading to hysterectomy,
55.8 and 53.5, respectively (Table 2). It should be noted
that almost 50% of the women with maternal near-miss
morbidity had multiple organ dysfunction. Mortality index
was highest for renal dysfunction, 40%. Maternal near-miss
mortality ratio was highest for uterine dysfunction (11:1),
followed by cardiovascular and coagulation/ hematologic
disorders (10:1). Of all the women with potentially life-
threatening conditions, 181 women (85.4%) underwent the
following critical interventions: 118 (55.7%) women used
blood products, 78 (36.8%) women had laparotomy and 75
(34.4%) women were admitted to ICU.
Underlying causes were similar among potentially life-
threatening conditions, near-miss cases and mater-
nal deaths, most common being severe postpartum
hemorrhage followed by hypertensive disorders (Table 3).
Associated conditions have also been assessed and the
most common reported conditions were anemia and
previous C-section, 55% and 44.5% among near-miss
women, respectively. Despite the small numbers, the
highest maternal near-miss mortality ratio among these
underlying causes was observed among women with
pregnancy-related infections (25%).
Majority of women with potentially life-threatening
conditions, near-miss cases and maternal deaths had
Table 1 Maternal near-miss terminology and indicators [8,9]
Maternal Near Miss (MNM) A woman who nearly died but survived a complication that occurred during pregnancy,
childbirth or within 42 days of termination of pregnancy.
Maternal Death (MD) Death of a woman while pregnant or within 42 days of termination of pregnancy or its
management, but not from accidental or incidental causes.
Live Birth (LB) The birth of an offspring, which breathes or shows evidence of life.




All women who either qualified as having maternal near miss or who died. It is the sum of
maternal near miss and maternal deaths.
Maternal Near Miss Ratio (MNMR) The number of maternal near miss cases per 1,000 live births.
Severe Maternal Outcome Ratio (SMOR) The number of women with life threatening conditions per 1,000 live births. This indication
gives an estimation of the amount of care and resources that would be needed in an
area or facility.
Maternal Near Miss Mortality Ratio: The ratio between maternal near-miss cases and maternal deaths. Higher ratios indicate
better care.
Mortality Index The number of maternal deaths divided by the number of women with life threatening conditions,
expressed as a percentage. The higher the index the more women with life-threatening conditions
die (low quality of care), whereas the lower the index the fewer women with life-threatening
conditions die (better quality of care).
Perinatal outcome indicators (e.g. perinatal mortality, neonatal mortality or stillbirth rates) in the context of maternal miss
could be useful to complement the quality of care evaluation.
Hospital Access Indicators:
The following indicators are used to explore
the access to the facility in terms of
functioning referral systems.
• SMO12: Cases presenting the organ dysfunction or maternal death within 12 hours of
hospital stay
• Proportion of SMO12 cases among all SMO cases
• Proportion of SMO12 cases coming from other facilities
• SMO12 mortality index: The number of SMO12 cases divided by the number of all SMO cases
expressed as a percentage.
Intra-hospital Care:
The following indicators are used to explore
access to quality care in the facility:
• Intra-hospital SMO: Cases presenting the organ dysfunction or maternal death after 12 hours
of hospital stay.
• Intra-hospital SMO rate (per 1000 live births): The number of intra-hospital SMO cases per 1000
live births.
• Intra-hospital mortality index: The number of intra-hospital SMO cases divided by the number of
all SMO cases expressed as a percentage.
• ICU admission rate: The number of women admitted to ICU among total number of
womengiving birth.
• ICU admission rate among women with SMO: The number of women with SMO divided by
the ICU admissions among total number of women giving birth.
Process Indicators:
The following indicators are used to assess
the coverage of selected evidence-based
interventions used for prevention and
treatment of the main causes of
maternal deaths.
• Prevention of postpartum hemorrhage: The number of women who received a single dose of
oxytocin divided by the number of all women giving birth (vaginal delivery + cesarean section)
• Treatment of severe postpartum hemorrhage: The number of women with severe PPH
who received therapeutic oxytocin divided by the number of all women with
postpartum hemorrhage.
• Eclampsia: The number of women with eclampsia who received magnesium sulfate divided
by the number of all women with eclampsia.
• Prevention of severe systemic infections/sepsis: The number of women having a cesarean
section and receiving prophylactic antibiotics divided by the number of all women having
cesarean sections.
• Treatment of severe infections and sepsis: The number of women with severe systemic infections
or sepsis who received IV antibiotics divided by the number of all women with severe systemic
infections or sepsis.
• Fetal lung maturation: The number of women having a live birth after 3 hours of hospital
stay and receiving corticosteroids for fetal lung maturation divided by all women having a
live birth after 3 hours of hospital stay.
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Table 2 Morbidity conditions leading to inclusion in a
sample of women with potentially life-threatening
conditions and severe maternal outcomes
n %
Women with potentially life-threatening conditions 212 100.00%
Women with severe complications 174 82.08%
Severe postpartum hemorrhage 84 39.62%
Severe Preeclampsia 4 1.89%
Eclampsia 43 20.28%
Sepsis or severe systemic infection 10 4.72%
Ruptured uterus 29 13.68%
Other complications associated with severe maternal
outcome
22 10.38%
Women undergoing critical Interventions 181 85.38%
Use of blood products 118 55.66%
Interventional radiology (uterine artery embolization) 2 0.94%
Laparotomy 85 40.09%
Admission to Intensive Care Unit 73 34.43%
Organ dysfunction in maternal near-miss cases 129 100.00%
Cardiovascular dysfunction 72 55.81%
Respiratory dysfunction 30 23.26%
Renal dysfunction 6 4.65%
Coagulation/hematologic dysfunction 30 23.26%
Hepatic dysfunction 5 3.88%
Neurologic dysfunction 23 17.83%
Uterine dysfunction/hysterectomy 69 53.49%
Multiple organ dysfunction 64 49.61%
Organ dysfunction in maternal deaths 16 100.00%
Cardiovascular dysfunction 7 43.75%
Respiratory dysfunction 8 50.00%
Renal dysfunction 4 25.00%
Coagulation/hematologic dysfunction 3 18.75%
Hepatic dysfunction 0 0.00%
Neurologic dysfunction 4 25.00%
Uterine dysfunction/hysterectomy 6 37.50%
Unspecified organ dysfunction 1 6.25%
Multiple organ dysfunction 9 56.25%
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outcomes (preterm births, stillbirths and perinatal
deaths) were worst among maternal deaths and compar-
able between women with potentially life-threatening
conditions and maternal near misses (Table 4). Overall,
there were no women with complete abortion reported
and ectopic pregnancy was highest among women with
potentially life-threatening conditions (18.4%) followed
by maternal deaths (6.3%).
The total maternal mortality ratio for the hospitals
was 62.8 per 100,000 live births. Severe maternaloutcomes and near-miss indicators can be found in
Table 5. The maternal near-miss ratio (MNMR) and se-
vere maternal outcome ratio (SMOR) were 5.06 and 5.69
per 1,000 live births, respectively (Table 5).
Access to Hospital and Care Indicators
Of the 145 cases with severe maternal outcomes (near
miss and maternal deaths), 127 cases (87.6%) presented
with the organ dysfunction or maternal death within the
first 12 hours of hospital admission and 34% of these
cases were referred from other facilities (Table 5). The
mortality indices for the first 12 hours of hospital admis-
sion and after 12 hours (intra-hospital) are 11.02% and
11.11%, respectively.
Among all the women giving birth at our study facil-
ities, the overall ICU admission rate was 0.28%, whereas
ICU admission rate among women with severe maternal
outcomes was 37.2% and proportion of maternal deaths
occurred with ICU admission was 50% (Table 6).
Process Indicators
Among women with severe maternal outcomes, oxytocin
was used in 86% of the women for the prevention of
postpartum hemorrhage, whereas only 68% of the
women with severe PPH received oxytocin as a treat-
ment agent among other treatment regimens. In 93% of
the eclampsia cases an anticonvulsant was used and
MgSO4 was used in 67% of these cases. Antibiotics were
used for all women with an established infection. In case
of caesarean section, 61% of women received prophylac-
tic antibiotics intra-operatively and the rest 39% were
given antibiotics post-operatively. Corticosteroids for
fetal lung maturity were used in only 55% of pregnant
women eligible for this type of treatment (Table 7).
Discussion
This study shows that in urban Iraq, the prevalence of ma-
ternal deaths and near-miss cases is relatively low. Despite
that, this study also highlights some opportunities to im-
prove care, both at the facility level and at the organization
of care / health system level. Some evidence-based prac-
tices, relevant to the management of women experiencing
life-threatening conditions, are underused. In addition,
possible limitations in the referral system result in a very
high proportion of women presenting at the hospital
already in a severe health condition (i.e. with organ dys-
function). A shortage of ICU beds may also contribute to
a high proportion of maternal deaths and organ dysfunc-
tion taking care without admission to ICU.
Comparing the major causes of near-miss cases and
maternal deaths, obstetric hemorrhage and hypertension
were the most common underlying causes of severe ma-
ternal outcomes, which is comparable to other studies in
developing countries [10-12]. In our study, anemia is






N= 212 N= 129 N= 16
n % n % n %
Underlying causes
Pregnancy with abortive outcome 44 20.75% 6 4.65% 1 6.25%
Obstetric Hemorrhage 99 46.70% 85 65.89% 7 43.75%
Hypertensive disorders 49 23.11% 27 20.93% 4 25.00%
Pregnancy-related infection 9 4.25% 4 3.10% 1 6.25%
Other obstetric disease or complication 28 13.21% 22 17.05% 1 6.25%
Medical/Surgical/Mental disease or complication 38 17.92% 26 20.16% 5 31.25%
Unanticipated complications of management 14 6.60% 11 8.53% 1 6.25%
Coincidental conditions 10 4.72% 8 6.20% 2 12.50%
Unknown 4 1.89% 3 2.33% 1 6.25%
Contributory causes / associated conditions
Anemia 96 45.28% 71 55.04% 8 50.00%
HIV infection 0 0.00% 0 0.00% 0 0.00%
Previous caesarean section 74 34.91% 58 44.96% 7 43.75%
Prolonged / obstructed labor 28 13.21% 21 16.28% 3 18.75%
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outcomes, and when compared with population level
data among Iraqi pregnant women (37.9%), this is a sta-
tistically significant difference, underlining the vulner-
able status of this sub-population [13].
In under-resourced settings there is a need to separate








Curettage / vacuum aspiration 7
Medical methods for uterine evacuation 0
Laparotomy for ectopic pregnancy 39
Other 4
Unknown 2
Women still pregnant at hospital discharge or death 7




*Caesarean deliveries divided by all deliveries / **fetal deaths + intra-hospital earlydevelop in the hospital setting as the former indicates a
failure in access to the facilities and/or to the referral
chain where such hospitals would need adequate
resources and organization to deal with such emergen-
cies [14]. In our study two thirds of women with SMO
developing within the first twelve hours of admission
were admitted without referrals, which may indicate andy population
atening conditions Maternal near-miss cases Maternal deaths
212 N= 129. N= 16
% n % n %
21.70% 37 28.68% 3 18.75%
50.47% 78 60.47% 11 68.75%
0.00% 0 0.00% 0 0.00%
3.30% 5 3.88% 0 0.00%
0.00% 0 0.00% 0 0.00%
18.40% 1 0.78% 1 6.25%
1.89% 2 1.55% 0 0.00%
0.94% 1 0.78% 0 0.00%
3.30% 5 3.88% 1 6.25%
69.93% n/a 67.83% n/a 78.57%
37.25% 42 36.52% 8 57.14%
20.92% 23 20.00% 6 42.86%
42.48% 50 43.48% 7 50.00%
neonatal mortality.
Table 5 Severe maternal outcomes and near miss
indicators
All live births in the population under surveillance 25,472
Severe maternal outcomes (SMO) cases (n) 145
Maternal Deaths (n) 16
Maternal near miss cases (n) 129
Overall near-miss indicators
Severe Maternal Outcome ratio (per 1000 live births) 5.69
Maternal near miss incidence ratio (per 1000 live births) 5.06
Maternal near miss mortality ratio 9:1
Mortality index 11.03%
Hospital access indicators
SMO cases presenting the organ dysfunction or maternal death
within 12 hours of hospital stay (SMO12) (n)
127
Proportion of SMO12 cases among all SMO cases 87.59%
Proportion of SMO12 cases coming from other health facilities 34.65%
SMO12 mortality index 11.02%
Intra-hospital care
Intra-hospital SMO cases (n) 18
Intra-hospital SMO rate (per 1000 live births) 0.71
Intra-Hospital mortality index 11.11%
Table 7 Process outcome indicators related with specific
conditions among women with severe maternal
outcomes (maternal near miss and maternal deaths)
n %
Prevention of postpartum hemorrhage
Target population: women giving birth in health facilities 132 100.00%
Oxytocin 114 86.36%
Any uterotonic (including oxytocin) 115 87.12%
Treatment of severe postpartum hemorrhage




Other uterotonics 3. 3.57%
Any of the above uterotonics 57 67.86%
Tranexamic acid 6 7.14%
Removal of retained products 16 19.05%
Balloon or condom tamponade 1. 1.19%
Artery ligation 4 4.76%
Hysterectomy 50 59.52%
Abdominal packing 4 4.76%
Proportion of cases with SMO 80 95.24%
Mortality 6. 7.14%
Anticonvulsants for Eclampsia
Target population: women with eclampsia 43 100.00%
Magnesium sulfate 29 67.44%
Other anticonvulsant 22 51.16%
Any anticonvulsant 40 93.02%
Proportion of cases with SMO 26 60.47%
Mortality 4 9.30%
Prevention of caesarean section related infection
Target population: women undergoing caesarean section 107 100.00%
Prophylactic antibiotic during caesarean section 65 60.75%
Treatment for sepsis
Target population: women with sepsis 10 100.00%
Parenteral therapeutic antibiotics 10 100.00%
Proportion of cases with SMO 6 60.00%
Mortality 2 20.00%
Ruptured uterus
Target population: women with ruptured uterus 29 100.00%
Laparotomy 28 96.55%
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nant women with life-threatening complications outside
these hospitals due to delay in seeking care or reaching
care. However it should be noted that in our study, the
overall mortality index is very similar between women
with severe maternal outcomes who were referred versus
in-hospital patients. This is in contrast to a similar study
where SMO was relatively higher among referred
women [12].
One of the key principles of effective management of
complications related to pregnancy and childbirth is
matching the level of care to the severity of the clinical
conditions. Women presenting complications may require
different levels of care, from basic obstetric care to inten-
sive care, including in this continuum comprehensive ob-
stetric care and surgery. Most of the women presenting
organ dysfunction would be more appropriately managed
at the ICU level [15]. The low ICU admission rates
observed in this study suggests an important shortage of
ICU beds, which is corroborated by the substantial pro-
portion of women experiencing organ dysfunction orTable 6 Intensive care use in our study population
All women giving birth 25,841
ICU admission rate 0.28%
ICU admission rate among women with SMO 37.24%
SMO rate among women admitted to ICU 73.97%
Proportion of maternal deaths occurred without ICU admission 50.00%
Laparotomy after 3 hours of hospital stay 5 17.24%
Proportion of cases with SMO 24 82.76%
Mortality 3 10.34%
Preterm birth
Target population: women having a preterm delivery after
3 hours of hospital stay
18 100.00%
Corticosteroids for fetal lung maturation 10 55.56%
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noted that two of the six hospitals had “close observation
units” instead of a proper ICU. Overall, the provision of
adequate critical care, with appropriate staffing, equip-
ment and management strategies can contribute to a bet-
ter outcome among women with life-threatening
conditions [15].
The use of a criterion-based clinical audit method-
ology within WHO near-miss approach revealed oppor-
tunities to improve care, where a target population with
a clear indication of an effective intervention is identified
and then the use of this specific intervention is assessed.
Among the hospitals in our study, magnesium sulfate
for treatment of eclampsia, oxytocin for prevention and
treatment of postpartum hemorrhage, prophylactic anti-
biotics during cesarean section, and corticosteroids for
inducing fetal lung maturation in preterm birth were all
underused. Of note, there were 5 cases of ruptured
uterus that had the laparotomy being performed after
three hours of hospital stay, suggesting an intra-hospital
delay in the management of obstructed labor.
This study has several strengths that deserve noting.
This is the first study assessing the quality of care in the
Iraqi facilities using the recent WHO maternal near-
miss definition and criteria. We collaborated with the
Iraqi Ministry of Health and by conducting the study
with the participation of the hospital staff and local cap-
acity strengthening, we aimed to create a long lasting
surveillance and quality improvement mechanism in
those hospitals, which can be replicated in other
resource-poor settings. There are some limitations as
well. Our study was conducted in only six hospitals in
Baghdad; therefore our results cannot be generalized to
the overall country. Also, we presented our data in ag-
gregate, however an in-depth analysis would be more
beneficial to assess the causes and contributory factors
in individual hospitals to improve quality of care. More
importantly this manuscript only describes our work to
evaluate the quality of care and our subsequent findings,
but does not cover the ongoing efforts to improve care
based on these results. Also, it should be noted that
we only collected data up to 7th day postpartum,
whereas the definition of near miss includes cases up
to 42 days.
Conclusions
The use of the WHO maternal near-miss approach
enabled the identification of important roadblocks to
improve quality of maternal care in Baghdad, Iraq. Our
results suggest that severe maternal outcomes can be
potentially reduced by fostering the use of evidence-
based interventions for life-threatening complications,
improving referral systems, and optimizing the use of
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